In non-muscle-invasive bladder cancer (NMIBC), HERV-H-derived miR-4454 is upregulated, which inhibits the expression of the tumor suppressor genes DNAJB4 and SASH1, thereby promoting NMIBC progression. This evidence concerns the gene DNAJB4 and neoplasm.